HINOON Stock Overview
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 4/6 |
Highnoon Laboratories Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | PK₨764.48 |
52 Week High | PK₨765.06 |
52 Week Low | PK₨330.00 |
Beta | 0.33 |
11 Month Change | 9.31% |
3 Month Change | 13.48% |
1 Year Change | 104.92% |
33 Year Change | 68.31% |
5 Year Change | 414.60% |
Change since IPO | 21,376.85% |
Recent News & Updates
Recent updates
Shareholder Returns
HINOON | PK Pharmaceuticals | PK Market | |
---|---|---|---|
7D | 13.0% | 9.5% | 0.9% |
1Y | 104.9% | 97.1% | 45.5% |
Return vs Industry: HINOON exceeded the PK Pharmaceuticals industry which returned 97.1% over the past year.
Return vs Market: HINOON exceeded the PK Market which returned 45.5% over the past year.
Price Volatility
HINOON volatility | |
---|---|
HINOON Average Weekly Movement | 4.2% |
Pharmaceuticals Industry Average Movement | 5.2% |
Market Average Movement | 5.3% |
10% most volatile stocks in PK Market | 9.3% |
10% least volatile stocks in PK Market | 3.2% |
Stable Share Price: HINOON has not had significant price volatility in the past 3 months.
Volatility Over Time: HINOON's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1984 | 2,295 | Adeel Haider | www.highnoon-labs.com |
Highnoon Laboratories Limited, together with its subsidiaries, manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products. It offers products in various therapeutic areas, including allergy, anti-infective, cardiology, gastroenterology, metabolic, musculoskeletal, obstetrics and gynaecology, paediatrics, respiratory, and urology; and generic products under various brands. The company serves Pakistan, Afghanistan, the United Arab Emirates, France, Kenya, Iraq, Cambodia, Tanzania, and internationally.
Highnoon Laboratories Limited Fundamentals Summary
HINOON fundamental statistics | |
---|---|
Market cap | PK₨40.50b |
Earnings (TTM) | PK₨2.64b |
Revenue (TTM) | PK₨20.95b |
15.3x
P/E Ratio1.9x
P/S RatioIs HINOON overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HINOON income statement (TTM) | |
---|---|
Revenue | PK₨20.95b |
Cost of Revenue | PK₨10.76b |
Gross Profit | PK₨10.19b |
Other Expenses | PK₨7.55b |
Earnings | PK₨2.64b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 49.88 |
Gross Margin | 48.65% |
Net Profit Margin | 12.61% |
Debt/Equity Ratio | 7.8% |
How did HINOON perform over the long term?
See historical performance and comparison